About Christopher O'Donnell
Christopher O'Donnell is a director at MindImmune Therapeutics.
Form D filings also name Christopher O'Donnell as a director at Triana Biomedicines and Strata Oncology.
Christopher O'Donnell first appears on SEC filings in 2022.
Experience
This experience comes from Christopher O'Donnell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher O'Donnell in the role, so the role may have started earlier or lasted longer.
CB
Cartography Biosciences Current
Board Member
2026 – Present
TR
TRexBio Current
Board Member
2026 – Present
MindImmune Therapeutics, Inc. Current
Member Board of Directors
2022 – Present · Kingston, RI
Develops immune-targeting drugs for people with Alzheimer's and other neurodegenerative diseases.
AT
Arrakis Therapeutics Current
Member Board Of Directors
2021 – Present
PO
Pyxis Oncology Current
Technical Advisory Board
2021 – Present
KT
Kestrel Therapeutics Current
Board of Directors
2021 – Present
IT
Incendia Therapeutics Current
Board of Directors
2021 – Present
SL
STORM Therapeutics Limited Current
Board Of Directors
2019 – Present
PF
Pfizer Current
Vice President - Business Development and Partner, Pfizer Ventures
1999 – Present
ET
Enlaza Therapeutics
Board Observer
2024 – 2026
AT
Arkuda Therapeutics
Board Of Directors
2019 – 2025
AB
Adapsyn Biosciences
Board Of Directors
2019 – 2024
BL
BioAtla LLC
Board Observer
2019 – 2020
PC
Petra Pharma Corporation
Board Observer
2019 – 2020
KT
Kymera Therapeutics
Board Of Directors
2018 – 2020
MT
Morphic Therapeutic
Board Observer
2018 – 2019
Key Colleagues at Startups
The people Christopher O'Donnell works with at each company, as listed on that company's latest Form D.
MindImmune Therapeutics, Inc. · Form D/A, Mar 5, 2026
Triana Biomedicines, Inc. · Form D, Dec 4, 2025
PT
Patrick Trojer
President and director
JR
Joshua Resnick
Director
JR
Jigar Raythatha
Director
DG
David Grayzel
Director
AH
Andrew Hedin
Director
LK
Lorence Kim
Director
SC
Shelley Chu
Director
Strata Oncology, Inc. · Form D, Nov 22, 2024
MM
Matthew Martin
Chief Financial Officer
DR
Daniel Rhodes
Executive officer and director
KF
Keith Flaherty
Director
JW
Jeffrey Williams
Executive officer and director
DR
David Rubin
Director
JP
James Pavlik
Director
JG
Jan Garfinkle
Director